Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients

Journal of Antimicrobial Chemotherapy

Volumn 48, Issue 1, 2001, Pages 97-103

  Boogaerts, Marc ^a   Maertens, Johan ^a   Van Hoof, Achiel ^b   De Bock, Robrecht ^c   Fillet, Georges ^d   Peetermans, Marc ^c   Selleslag, Dominik ^b   Vandercam, Bernard ^e   Vandewoude, Koenraad ^f   Zachée, Pierre ^c   De Beule, Karel ^g  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b General Hospital St Jan   (Belgium)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

^g JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; NYSTATIN; POLYENE ANTIBIOTIC AGENT;

ADULT; ARTICLE; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; FECES; FEMALE; HUMAN; INCIDENCE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOSIS; NAUSEA; NEUTROPENIA; NOSE; NOSE SEPTUM; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; TREATMENT FAILURE;

EID: 0034926627     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/48.1.97     Document Type: Article

References (18)

1. Current clinical issues on mycoses in neutropenic patients
2. Antifungal agents: A review of their pharmacology and therapeutic indications
3. New therapies for onychomycosis
4. Resistance of yeasts to azole-derivative anti-fungals
5. Fluconazole and itraconazole: Current status and prospects for antifungal therapy
6. Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: Animal models
7. The in-vitro antifungal spectrum of itraconazole
8. Antifungal prophylaxis with itraconazole in prolonged neutropenia: Correlation with plasma levels
9. Itraconazole: Pharmacology, clinical experience and future development
10. Candida colonization and subsequent infections in critically ill surgical patients
11. Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: A randomized, placebo-controlled, double-blind, multicenter trial
12. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies
13. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: A randomized, double-blind, double-placebo, multicenter trial comparing amphotericin B
14. Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology
15. Food interaction and steady-state pharmacokinetics of itraconazole oral solution in healthy volunteers
16. Effect of food on the pharmacokinetics of a new hydroxypropyl-beta-cyclodextrin formulation of itraconazole
17. Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual frame-work and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Susceptibility Testing of the National Committee for Clinical Laboratory Standards
18. Lack of interaction of antacid drug omeprazole on the bioavailability of itraconazole oral solution